Deera Investment & Real Estate Development Co. (ASE:DERA)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21	18	22	22	29	33
Market Cap Growth	-28.57%	-16.67%	-3.57%	-22.22%	-13.25%	9.21%
Enterprise Value	44	37	42	49	48	52
Last Close Price	0.52	0.45	0.54	0.56	0.68	0.78
PS Ratio	3.10	2.73	1.57	3.02	5.03	7.73
PB Ratio	0.47	0.40	0.45	0.48	0.54	0.58
P/TBV Ratio	0.47	0.40	0.45	0.48	0.55	0.60
P/FCF Ratio	-	-	49.78	5.18	-	57.21
P/OCF Ratio	-	-	27.06	4.46	-	56.73
EV/Sales Ratio	6.61	5.66	3.08	6.55	8.33	12.09
EV/EBITDA Ratio	226.35	252.03	28.74	-	-	-
EV/EBIT Ratio	-	-	51.76	-	-	-
EV/FCF Ratio	-15.55	-	97.62	11.22	-	89.48
Debt / Equity Ratio	0.54	0.50	0.44	0.54	0.50	0.32
Debt / EBITDA Ratio	121.31	150.98	14.28	-	-	-
Debt / FCF Ratio	-	-	48.50	5.89	-	31.09
Asset Turnover	0.09	0.09	0.18	0.09	0.07	0.05
Inventory Turnover	0.57	0.56	1.22	0.51	0.36	0.28
Quick Ratio	0.19	0.20	0.18	0.12	0.11	0.06
Current Ratio	1.47	1.39	1.34	1.02	2.14	1.67
Return on Equity (ROE)	-6.50%	-6.53%	-0.51%	-7.59%	-6.34%	-4.58%
Return on Assets (ROA)	-0.38%	-0.41%	0.66%	-0.59%	-1.05%	-1.10%
Return on Capital (ROIC)	-0.41%	-0.44%	0.72%	-0.64%	-1.18%	-1.28%
Return on Capital Employed (ROCE)	-	-	1.20%	-	-	-
Earnings Yield	-14.05%	-16.91%	-1.13%	-16.98%	-11.50%	-7.08%
FCF Yield	-13.73%	-11.05%	2.01%	19.30%	-5.99%	1.75%
Dividend Yield	-	-	-	-	5.91%	-
Total Shareholder Return	-	-	-	-	5.91%	-

Updated Feb 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.